The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Synchron has raised $200 million to support commercialization of its brain computer interface platform, the company said Thursday. The Series D round will fund preparations to launch Synchron's ...

In 2019, Elon Musk brought his latest high-tech venture out of the shadows, unveiling plans for an implanted brain chip that would be capable of simultaneously tracking and stimulating neurological ...

The neurotech startup Synchron is building a brain implant to try and help patients with paralysis control their phones, computers and other devices with their minds. The company announced Thursday ...

Exciting startup Synchron offers a revolutionary brain-computer interface solution for people with paralysis and other conditions Clinical trial demonstrates their non-invasive brain procedure could ...

Neurotech startup Synchron is ramping up production of its flagship brain-computer interface to prepare for commercial demand, as the company inches closer to bringing its device to market. Synchron, ...

Thanks to the success of an initial safety trial for an implantable device that can translate the brain’s electrical impulses into readable signals, we’re a step closer to being able to text—or ...

One year down, a lifetime to go. New results from Synchron’s first human study of its brain-computer interface system—a permanent, stent-like implant—found that one year after the device’s placement, ...

Brain-computer interfaces have become a practical (if limited) reality in the US. Synchron says it has become the first in the country to implant a BCI in a human patient. Doctors in New York's Mount ...

NEW YORK--(BUSINESS WIRE)--Synchron, a brain-computer interface company, and Team Gleason, a foundation dedicated to improving the lives of people living with Amyotrophic Lateral Sclerosis (ALS), ...

NEW YORK--(BUSINESS WIRE)--Synchron, a brain computer interface (BCI) company, today announced the results from a study in which four people with ALS received an implant of Synchron’s Stentrode™ ...

Synchron has raised a $200 million Series D financing round to accelerate the commercialization of its Stentrode brain-computer interface platform and advance the development of a next-generation ...